Texas Instruments will buy Austin-based Silicon Labs for $231 a share in a $7.5B cash deal that folds the wireless‑chip maker into TI’s U.S. manufacturing network. Closing is expected in the first half of 2027.

ActiveCampaign bought Feedback Intelligence to speed improvements to its Active Intelligence AI. Founder Chinar Movsisyan will join the Chicago firm's product team.

A University of Florida study revealed multiple small errors led to the collapse of hurricane-resistant light poles during Hurricane Ian, including manufacturing flaws, design issues, and installation errors.

Adtalem — the largest U.S. health-care educator — announced a corporate rebrand to Covista and a new push into research, training and philanthropy to help ease staffing shortages.

A developer pitched a $2 billion AI center for East St. Louis, promising jobs, retail space and river‑based cooling while asking for community support. The plan is still early and would need city approval.

Athena gives NASA a 20+ petaflop boost at Ames, cutting major simulations from weeks to days and supporting Artemis‑era missions.

A San Diego‑led team mapped nine CD8 T‑cell states and identified two transcription factors that revive exhausted T cells without erasing immune memory. The finding points to new cell‑therapy strategies.

ERCOT's new 'batch' interconnection plan could put about 8.2 GW of approved data‑center load back under review, forcing clearer timelines and staged commitments.

Medtronic will acquire CathWorks and its AI FFRangio system in a deal worth up to $585M, folding a wire‑free coronary diagnostic into its cath‑lab offerings.

A new Austin survey finds 61% of residents worry AI could displace jobs and many fear deepfakes and a loss of the human touch. Local leaders are pressing for reskilling.

San Diego biotech Neomorph has dosed the first patient in a Phase 1/2 trial of NEO‑811, a molecular glue for clear‑cell kidney cancer, after landing multibillion‑dollar pharma deals. Early safety and activity readouts will be the near‑term test.

University of Cincinnati Cancer Center researchers aim to develop new glioblastoma treatments using "glioblastoma-on-a-chip" and immunostimulatory wafers following surgery.

Two University of Florida scholars influenced Mars mission planning with their report on science goals for the Red Planet, prioritizing the search for life and other scientific explorations.